VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,152,791 | -54.9% | 123,030 | +18.1% | 0.00% | -66.7% |
Q2 2023 | $2,554,750 | +12.7% | 104,148 | +7.0% | 0.00% | 0.0% |
Q1 2023 | $2,266,009 | +18.4% | 97,379 | +28.7% | 0.00% | +50.0% |
Q4 2022 | $1,914,524 | +490.9% | 75,643 | +350.5% | 0.00% | – |
Q3 2022 | $324,000 | -34.3% | 16,791 | -13.3% | 0.00% | -100.0% |
Q2 2022 | $493,000 | +17.9% | 19,372 | -5.7% | 0.00% | – |
Q1 2022 | $418,000 | -4.6% | 20,545 | +96.2% | 0.00% | – |
Q4 2021 | $438,000 | -1.1% | 10,472 | +2.8% | 0.00% | – |
Q3 2021 | $443,000 | +6.2% | 10,188 | +15.6% | 0.00% | – |
Q2 2021 | $417,000 | -4.6% | 8,811 | +3.5% | 0.00% | – |
Q1 2021 | $437,000 | +90.8% | 8,515 | -0.2% | 0.00% | – |
Q4 2020 | $229,000 | -32.6% | 8,536 | -13.8% | 0.00% | – |
Q3 2020 | $340,000 | -6.8% | 9,898 | +11.0% | 0.00% | – |
Q2 2020 | $365,000 | -24.3% | 8,921 | -36.6% | 0.00% | – |
Q1 2020 | $482,000 | – | 14,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |